Mumbai: Amanta Healthcare Limited, a pharmaceutical company that develops, manufactures and markets sterile liquid products, will list its IPO on the bourses on September 01, 2025 for 1 lakh equity shares of Rs.10 for a price band of Rs.120-126 per equity share.
The company aims to raise Rs.126 crore through the issue for expanding its operations at Hariyala, Gujarat. The proceeds will be used to fund the civil construction and the purchase of equipment for expansion, besides other corporate uses.
Half of the net issue has been reserved for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs) and the rest for retail investors.
“Our company has grown by developing and supplying a wide range of sterile liquid products across therapeutic segments and medical devices. We have established a presence across domestic and international markets. This IPO marks a step forward in our growth journey, allowing us to expand our manufacturing capabilities with new SteriPort and SVP lines at our Hariyala facility, which will strengthen our capacity and support us for future plans,” Mr. Bhavesh Patel, Chairman and Managing Director of Amanta Healthcare Limited, said.
The IPO will be open for subscription till September 03, with the shares to be listed on September 08.
The company had reported a revenue of Rs.276 crore in FY25, slightly lower than the Rs.281.61 crore reported in FY24. However, its Profit After Tax (PAT) surged 189% to Rs.10.5 crore in FY25 from Rs.6.63 crore a year earlier.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Investing in stocks includes financial risks, and past performance is not indicative of future results. Readers should conduct their own research or consult with a qualified financial advisor before making any investment decisions.
